Navigation Links
VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
Date:4/4/2008

ated to

our product candidates;

-- our potential for future growth and the development of our product

pipeline;

-- our ability to form and maintain collaborative relationships to

develop and commercialize our product candidates;

-- general economic and business conditions; and

-- the other risks described under Item IA "Risk Factors" in our Annual

Report on Form 10-K for the fiscal year ended December 31, 2007 on

file with the SEC.

All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. Forward-looking statements speak only as of the date they are made, and VIA undertakes no obligation to update publicly any of these statements in light of new information or future events.


'/>"/>
SOURCE VIA Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
3. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
4. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
5. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
6. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
7. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
8. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
9. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. VIA Pharmaceuticals Completes Enrollment In Phase 2 Carotid Endarterectomy (CEA) Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...NEW YORK, Nov. 20 Reportlinker.com...ailable in its catalogue. ,, Global Markets fo...://www.reportlinker.com/p0164742/Global-Markets-fo...ce=prnewswire&utm_medium=pr&utm_campaign=p...oduction covers the U.S., 15 Countries in Europe a...
(Date:11/20/2009)...USTON, Nov. 20 Cyberonic...Moore, President and Chief Executive Officer, and ... at the 21st Annual Piper Jaffray Health Care Conf...at 12:00 PM EST. The conference session and webca... presented. Piper Jaffray will host a webcast of ...
(Date:11/20/2009)...NCETON, N.J., Nov. 20 So...x or the Company), formerly known as DOR BioPharma...ced today that it has formed a consortium to devel...d other rapidly acting vaccines. Soligenix receive... of Allergy and Infectious Diseases (NIAID), a div...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 1Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 2Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 3National Infertility Organization Honors RMA of New York for Community Support 47782 1National Infertility Organization Honors RMA of New York for Community Support 47782 2Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 1Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 2Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 3Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 4
(Date:11/21/2009)...ental Group merges their practice with that of E. ... (PRWEB) November 21, 2009 -- The N...avid Gibson, Dr. Dean Cloutier, Dr. John Plachtyna...owing practice with that of esteemed colleague Dr....e wanted to retire from dentistry in order to conc...
(Date:11/20/2009)...RNewswire-FirstCall/ - NUCRYST Pharmaceuticals Cor...holders will be held on Monday, December 21, 2009....l of two special resolutions. The first special re...ll or substantially all of the assets of NUCRYST, ...et purchase agreement dated November 10, 2009 amon...
(Date:11/20/2009)...Newswire/ -- Following a recall by Unilever The St...e Shedd,s Country Crock ® Side Dishes DELUXE ...174; Side Dishes DELUXE Four Cheese Pasta due to a...g code dates and UPCs are affected: ,, Shedd,s...roccoli Rice 21 oz, UPC 027400218316, Best By NOV ...
(Date:11/20/2009)...re-USNewswire/ -- The American Dental Association ...ation (FDA) to establish appropriate classificatio...ncern about the safety of whitening products that ...essional consultation or examination by a dentist,...ically based tooth whitening or bleaching agents c...
(Date:11/20/2009)...20 Samuel Gladding is n... it means to be "happy" during the holidays. As a ...n family counseling and chair of the Department of...ys research shows that it is the pressure to be ha...n during the holidays. ,, That,s why he,s chall...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...ames Smith, a former psychiatric patient has been ...Robertson to death in October last year in a Glasg...s than a year after being // released from a psych...gow, befriended James Smith while they were both p...
...he rate of Caesarean sections in the US has climbe...em down. According to the National Center for...ere performed in 2004—29.1 // percent of all birth...time pregnancies with a full-term, single child. T...
... revolutionary research study hints at the evidenc...y offer protection from axonal injury and induced ...sing remitting multiple sclerosis (RRMS). // ... in relapsing remitting multiple sclerosis. The mo...
...n Association for International Cancer Research te...natural compound found in glucose blocks the devel...vital in fighting cancer and // related illnesses....umor by blocking blood and nutrient supply to it. ...
...ondon: A complex natural sugar could be the answer...ex natural sugar from the glucose family that bloc...s online edition of New Scientist. // The te...ts, the sugar molecules were divided and purified ...
...esearchers have found that co-infection of two gen...ake the patients susceptible to malarial parasite ...mia and Patients with Sickle Cell anemia were resi...dings of the research were presented in the Fourth...
Other Medicine News:Health News:Man Bludgeons Friend, Gets Life Term 2Health News:Caesareans In U.S. At All-Time High 2Health News:Help at hand for RRMS patients 2Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 2Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 3Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 4
Cholesterol/HDL Standard
HDL Cholesterol
Ammonia Reagent
...tions over a wide range of concentration, temperat...gh characterization than other methods. Its unique...e in the distribution of molecular weights, provid...ichiometry and self-associating systems. The Prote...
Medicine Products: